Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 9Colorectal Neoplasms 4Head and Neck Neoplasms 3Colonic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Stage IA Pancreatic Adenocarcinoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1HER2-positive Gastric Cancer 1Fruquintinib 1For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method 1Extrapancreatic Neuroendocrine Tumor 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1Adenoma, Islet Cell 1

Interventions

Tegafur 1Gemcitabine 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Stage IA Pancreatic Adenocarcinoma × Tegafur × Clear all
NCT04216758 2020-06-30

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

Fudan University

Phase 2 Unknown
300 enrolled
Gastrointestinal

Stage IA Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡